Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Cancer Chemotherapy and Pharmacology
|
January 14, 2011
Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma
Makiko Mori, Mamoru Tsukuda, Hideki Matsuda, et al.
Head & Neck
|
May 5, 2016
Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapy
Kenichiro Yabuki, Daisuke Sano, Osamu Shiono, et al.
Cancer Science
|
August 14, 2009
Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma
Shigeyuki Ozawa, Yasumasa Kato, Shin Ito, et al.
Cancer Chemotherapy and Pharmacology
|
December 25, 2009
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck
Mamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2013
Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy
Takahide Taguchi, Goshi Nishimura, Masahiro Takahashi, et al.
Nihon Jibiinkoka Gakkai Kaiho
|
March 16, 2005
[Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)]
Hideaki Katori, Mamoru Tsukuda, Junichi Ishitoya, et al.
Cancer Chemotherapy and Pharmacology
|
February 17, 2009
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity
Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
International Journal of Molecular Medicine
|
July 14, 2005
Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 cases
Yasumasa Kato, Yoji Nagashima, Yuh Baba, et al.
Plos One
|
June 9, 2018
Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study
Akira Kubota, Eiji Nakatani, Kiyoaki Tsukahara, et al.
Plos One
|
February 12, 2015
Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC)
Kiyoaki Tsukahara, Akira Kubota, Yasuhisa Hasegawa, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Cancer Chemotherapy and Pharmacology
|
January 14, 2011
Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma
Makiko Mori, Mamoru Tsukuda, Hideki Matsuda, et al.
Head & Neck
|
May 5, 2016
Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapy
Kenichiro Yabuki, Daisuke Sano, Osamu Shiono, et al.
Cancer Science
|
August 14, 2009
Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma
Shigeyuki Ozawa, Yasumasa Kato, Shin Ito, et al.
Cancer Chemotherapy and Pharmacology
|
December 25, 2009
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck
Mamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2013
Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy
Takahide Taguchi, Goshi Nishimura, Masahiro Takahashi, et al.
Nihon Jibiinkoka Gakkai Kaiho
|
March 16, 2005
[Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)]
Hideaki Katori, Mamoru Tsukuda, Junichi Ishitoya, et al.
Cancer Chemotherapy and Pharmacology
|
February 17, 2009
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity
Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
International Journal of Molecular Medicine
|
July 14, 2005
Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 cases
Yasumasa Kato, Yoji Nagashima, Yuh Baba, et al.
Plos One
|
June 9, 2018
Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study
Akira Kubota, Eiji Nakatani, Kiyoaki Tsukahara, et al.
Plos One
|
February 12, 2015
Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC)
Kiyoaki Tsukahara, Akira Kubota, Yasuhisa Hasegawa, et al.
Page
of 7